Phase I-II Study of Idarubicin, Cytarabine, and Sorafenib (BAY43-9006)

Clinical trial NCT00542971 · COMPLETED

Trial details

NCT number: NCT00542971
Sponsor: M.D. Anderson Cancer Center
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

AML Acute Myeloid Leukemia Myelodysplastic Disorders

Start date: 2007-10-01
Primary completion: 2011-05-01
Enrollment: 78

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.